We are live on ! Find out more
AAM

Auxier Asset Management Portfolio holdings

AUM $696M
1-Year Est. Return 18.07%
This Fund
S&P 500
This Quarter Est. Return
+15.48%
1 Year Est. Return
+18.07%
3 Year Est. Return
+58.42%
5 Year Est. Return
+82.9%
10 Year Est. Return
+252.62%
AUM
$453M
AUM Growth
+$52.8M
Cap. Flow
-$2.57M
Cap. Flow %
-0.57%
Top 10 Hldgs %
34.67%
Holding
155
New
5
Increased
18
Reduced
80
Closed
8

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$1.9M
2
ABBV icon
AbbVie
ABBV
+$630K
3
BMY icon
Bristol-Myers Squibb
BMY
+$549K
4
FORR icon
Forrester Research
FORR
+$444K
5
PFE icon
Pfizer
PFE
+$408K

Top Sells

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$1.64M
2
AGN
Allergan plc
AGN
+$1.48M
3
BIIB icon
Biogen
BIIB
+$586K
4
ABT icon
Abbott
ABT
+$502K
5
MSFT icon
Microsoft
MSFT
+$441K

Sector Composition

Rank Sector Weight
1 Healthcare 28.41%
2 Consumer Staples 17.95%
3 Financials 17.53%
4 Technology 10.41%
5 Consumer Discretionary 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDNW
151
RideNow Group
RDNW
$265M
-3,200
Closed -$13K
TPR icon
152
Tapestry
TPR
$31.6B
-10,145
Closed -$131K
PYX
153
DELISTED
Pyxus International, Inc.
PYX
-13,585
Closed -$42K
AGN
154
DELISTED
Allergan plc
AGN
-8,365
Closed -$1.48M
RTN
155
DELISTED
Raytheon Company
RTN
-12,500
Closed -$1.64M

Similar funds

Auxier Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Auxier Asset Management held 155 positions worth $453M, up 13% from $401M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Auxier Asset Management's Q2 2020 filing shows 5 new, 18 increased, 80 reduced and 8 closed positions. Its largest new stake was RTX Corp: 30,516 shares worth $1.88M. The largest sale was Raytheon Company, an estimated $1.64M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Consumer Staples and Financials.

  • Auxier Asset Management's largest Q2 2020 buy was RTX Corp: 30,516 shares worth $1.88M.
  • Auxier Asset Management added most to AbbVie in Q2 2020, an estimated $630K increase.
  • Auxier Asset Management's biggest Q2 2020 reduction was Biogen, cutting an estimated $586K.
  • Auxier Asset Management fully exited Raytheon Company in Q2 2020, selling an estimated $1.64M.
  • Auxier Asset Management's ten largest holdings make up 35% of its $453M portfolio in Q2 2020.
  • Auxier Asset Management opened 5 new positions and closed 8 in Q2 2020.
  • Auxier Asset Management's portfolio value rose 13% quarter-over-quarter to $453M.

Based on Auxier Asset Management's 13F filing for Q2 2020, filed 20 Aug 2020.